UC Davis Health and Amazon Web Services are collaborating on a cloud innovation center in Sacramento to explore new techniques to deliver health care without going to a hospital. Read More...
Motley Fool
Is Now the Right Time to Buy NovoCure?
NovoCure (NASDAQ: NVCR) was one of the better-performing stocks of early 2021, but the big gains came to an end in June. Is the recent plunge an opportunity to buy a great medical device stock on sale, or is it the beginning of a longer slide? NovoCure’s flagship product, Optune, is a weird-looking, battery-powered hat that generates electric fields in order to disrupt cancer cell division.
